Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
Abdel-aleem
S
S
Duke University Medical Center, Dept. of Surgery, Durham, North Carolina, USA.
Sharwi
S
S
Badr
M
M
Sayed-Ahmed
M
M
Anstadt
M P
MP
Lowe
J E
JE
D000818:Animals; D050260:Carbohydrate Metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism* / Q000473:pathology*; D004305:Dose-Response Relationship, Drug; D004852:Epoxy Compounds / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism*; D005947:Glucose / Q000096:biosynthesis / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000166:cytology*; D010084:Oxidation-Reduction; D010168:Palmitates / Q000378:metabolism; D011768:Pyruvate Dehydrogenase Complex / Q000037:antagonists & inhibitors; D011773:Pyruvates / Q000378:metabolism; D019289:Pyruvic Acid; D051381:Rats; D017207:Rats, Sprague-Dawley
D004852:Epoxy Compounds; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D010168:Palmitates; D011768:Pyruvate Dehydrogenase Complex; D011773:Pyruvates; D019289:Pyruvic Acid; D005947:Glucose; C054207:etomoxir